CSE: FNDX | OTCQB: FDXTF | FSE: E8D

FendX is a nanotechnology company focused on reducing the spread of pathogens to keep surfaces safe from contamination.

November 14, 2024 2:35 am

Financial Statements

Corporate Governance

Insider Trading Policy

Corporate Governance and Policy Manual

Frequently Asked Questions

Where is FendX's corporate headquarters?

FendX’s corporate headquarters is located at 2010 Winston Park Dr., 2nd Floor, Oakville, ON L6H 5R7.

FendX was incorporated on July 28, 2020 under the Business Corporations Act (British Columbia).

Dr. Carolyn Myers, President and Chief Executive Officer

Rose Zanic, CPA, CA, Chief Financial Officer

Andrea Mulder, Chief Operating Officer

Learn more about our management team here

Dr. Carolyn Myers

Stephen Randall

Pierre Soulard

Learn more about our Board of Directors here.

Yes. To add yourself to our mailing list, please click below.

December 31

 

Period End

Reporting Due Date

AFS

December 31, 2022

May 1, 2023

Q1

March 31, 2023

May 30, 2023

Q2

June 30, 2023

August 29, 2023

Q3

September 30, 2023

November 29, 2023

You can download our investor materials on the Investors page.

Dale Matheson Carr-Hilton LaBonte LLP, Chartered Professional Accountants (“DMCL”)

FendX stock is traded on the CSE under the symbol “FNDX”, on the OTCQB under “FDXTF”, and on the FSE under “E8D”.

FendX’s CUSIP is 314460106

FendX’s ISIN is CA3144601067

You can purchase FendX stock through just about any brokerage firm, including online services.

FendX is listed on the CSE under the symbol “FNDX”, on the OTCQB under “FDXTF”, and on the FSE under “E8D”.

No, you can purchase FendX stock through just about any brokerage firm, including online services

Endeavor Trust Corporation 777 Hornby St #702, Vancouver, BC V6Z 1S4

1-604-559-8880 – Head Office

info@EndeavorTrust.com